podophyllotoxin has been researched along with Thrombocytopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberto, P; Giger, K; Nagel, G; Senn, HJ; Sonntag, RW | 1 |
| Bross, T; Bross, W; Olejak, B | 1 |
1 trial(s) available for podophyllotoxin and Thrombocytopathy
| Article | Year |
|---|---|
Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Anemia, Aplastic; Antineoplastic Agents; Blood Platelet Disorders; Child; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Glycosides; Hematopoiesis; Hodgkin Disease; Humans; Lactones; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Remission, Spontaneous; Thiophenes; Urinary Bladder Neoplasms | 1972 |
2 other study(ies) available for podophyllotoxin and Thrombocytopathy
| Article | Year |
|---|---|
Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis.
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelet Disorders; Dose-Response Relationship, Drug; Female; Glucosides; Glycosides; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Thiophenes | 1974 |
[On a long lasting remission of myelocytic leukemia following cytostatic therapy].
Topics: Antineoplastic Agents; Blood Platelet Disorders; Humans; Injections, Intravenous; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Splenic Diseases | 1966 |